Processa Pharmaceuticals, Inc. has filed a prospectus supplement allowing the sale of $5,239,073 worth of common stock through its equity distribution agreement with A.G.P. / Alliance Global Partners. In the past 12 months, the company has already sold $1,546,338 worth of shares, leaving $3,692,735 available for future sales. The document does not specify the price per share.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-011419), on July 25, 2025, and is solely responsible for the information contained therein.